[Postoperative septic complications in patients operated on for thoracic neoplasms].
The authors executed a prospective clinic study evaluating, whether at the admittance or after surgery, the immunity status of 30 patients with a thoracic neoplasm, admitted to Department of Thoracic Surgery, I School of Medicine, Naples. Only 21 of them, immunodepressed at the admittance, were accepted to trial and assigned respectively to A Group destined to surgery (10 patients) and to B check Group (11 patients). In the A Group the effectiveness of the immunotherapy was valued in the prophylaxis and in the postoperative septic complications' therapy. The global incidence of those complications was of 6 cases, of which 10% only in A Group and 45% in B Group. In the operated patients the septic complications had few repercussions on general status and were rapidly and totally dominated in strict correlation with an adequate immunoreconstitution.
Biondo
F G
FG
I Facoltà di Medicina e Chirurgia, Chirurgia Toraco-Polmonare, Università degli Studi di Napoli.
Caldarelli
L
L
Bergaminelli
C
C
Cesarano
T
T
Di Crescenzo
V G
VG
Santini
M
M
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D016867:Immunocompromised Host / Q000187:drug effects / Q000276:immunology; D007558:Italy / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D011446:Prospective Studies; D013899:Thoracic Neoplasms / Q000150:complications* / Q000276:immunology / Q000601:surgery
D000276:Adjuvants, Immunologic
Le complicanze settiche postoperatorie nei pazienti operati per neoplasie del torace.